Can I get a loan on patents that are not yet generating revenue?

Short Answer

Rarely on their own. Mainstream lenders service debt from operating cash flow, so pre-revenue patents usually need attributable income, insurance backing, or another repayment source to support a loan.

Full Explanation

The honest answer is that pre-revenue patents alone rarely support a conventional loan, and the reason is structural rather than a reflection of the patent's quality. Lenders repay debt from operating cash flow first; collateral is the secondary, fallback source. A patent with no attributable income gives a credit team a strong asset but no serviceability, and over-reliance on collateral is a recognised underwriting failure. The World Intellectual Property Organization makes the same point: the preferred collateral is licensed IP with attributable royalty income, because the loan is serviced from the revenue or royalties the IP underpins. Without that revenue link, the case is much harder to make. That said, it is not impossible, and there are recognised routes. Insurance-wrapped or specialist lenders, working with providers of IP-backed insurance and residual value insurance, can lend against IP at loan-to-values that reach towards 50 per cent, because the insurance transfers some of the recovery risk. NatWest's High Growth IP Loan and HSBC's growth-lending activity treat IP as a fallback within a wider facility, but their eligibility still leans on demonstrable growth and trading, not IP alone; NatWest, for example, looks for high-growth characteristics such as sustained turnover growth or recent equity investment. A sale-and-licence-back can also unlock cash from IP while the business continues to use it. Non-dilutive funding against pure pre-revenue IP, though, remains a specialist niche. Whatever the route, the fundamentals still apply. The patents must be in force with renewals paid, held with clean, unencumbered legal title and a documented chain of title, with any contractor or employee IP properly assigned. Registered rights carry more weight than unregistered know-how, and a lender will run encumbrance searches at Companies House and the UK IPO and commission an independent IP audit before lending. Even where revenue is thin, freedom to operate and enforceable title do the heavy lifting. As a next step, focus on building the bridge to revenue that a lender needs to see: a licence with attributable royalty income, a committed pipeline, or an insurance wrapper, alongside a clean title file. If you are genuinely pre-revenue, an equity raise or grant funding may fit better today, with IP-backed borrowing following once income arrives. Assembling the register, valuation and evidence early, which the Opagio collateral pack is built to do, means you are ready the moment the revenue case matures.

Try It Yourself

ip-lending

Related Glossary Terms

Royalty Income Lending Revenue Attributable to IP IP-Backed Insurance Sale-and-Licence-Back Non-Dilutive Funding

Related Questions

What is EBITDA and why does it matter for valuation?

EBITDA (Earnings Before Interest, Tax, Depreciation, and Amortisation) strips out financing and accounting decisions to show a company's core operatio...

How much can I borrow against my IP?

Typically up to around half your independently appraised IP value, so a £4m valuation might support a facility of roughly £2m, subject to your cash fl...

What loan-to-value ratio do lenders offer on intellectual property?

Indicatively, IP loan-to-value runs from around 20-40% in the broader market up to roughly 50% for registered, insurance-backed rights, against an ord...

Want to see these concepts in action?

Discover how Opagio Intangibles puts intangible asset theory into practice.